ARTICLE | Company News
Helsinn Healthcare SA, Therabel Pharma NV sales and marketing update
February 13, 2006 8:00 AM UTC
Helsinn granted Therabel exclusive rights to market and distribute Aloxi palonosetron in France, Belgium, Luxemburg and the Netherlands. The second-generation serotonin (5-HT3) antagonist is approved...